Position in NAGE
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$5,521,138
-$551,898 QoQ
Shares Held
1,251,959
+31.1% QoQ
Ownership
1.57%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NAGE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GOLDMAN SACHS GROUP INC holds $10,294,260,512 across 365 Biotechnology names. NAGE ranks #175 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,417,875 | $1,079,677,898 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,300,558 | $1,004,863,129 | |
| 3 | MRNA |
Moderna, Inc.
|
6,603,697 | $335,467,805 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
11,111,591 | $307,791,069 | |
| 5 | PRAX |
Praxis Precision Medicines, Inc.
|
710,734 | $228,991,385 | |
| 6 | INCY |
Incyte Corp
|
2,351,221 | $221,296,919 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
2,185,500 | $212,539,874 | |
| 8 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
1,965,432 | $170,933,620 |
All Filings in NAGE
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,521,138 | 1,251,959 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $6,073,036 | 954,880 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $3,532,580 | 378,626 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $2,614,348 | 181,426 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,845,148 | 267,413 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $908,434 | 171,080 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $529,347 | 145,027 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $206,027 | 75,468 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $668,943 | 192,225 | Shares | Defined | 2024-05-15 | |
| 2022-09-30 | $16,437 | 13,364 | Shares | Defined | 2024-05-14 | |
| 2022-06-30 | $539,539 | 323,078 | Shares | Defined | 2024-05-14 | |
| 2022-03-31 | $874,180 | 355,358 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,612,410 | 431,126 | Shares | Defined | 2022-02-17 | |
| 2021-09-30 | $2,208,870 | 352,292 | Shares | Defined | 2022-01-20 | |
| 2021-06-30 | $3,757,862 | 381,122 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $4,364,703 | 467,313 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $482,870 | 100,598 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $345,593 | 86,183 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $239,941 | 52,275 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $150,324 | 46,112 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||